Docexan 80 Docetaxel Ramucirumab
MinorIn patients with solid tumours, taking ramucirumab with docetaxel in the approved combinations did not cause any clinically meaningful change in how much of either drug the body was exposed to. The same was true for paclitaxel, irinotecan (or its active form, SN-38) and erlotinib.
Little or no effect is expected. You usually do not need to change anything, but still tell your doctor or pharmacist about every medicine you take.